Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
 12 Months Ended 60 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Cash flows from operating activities      
Net loss $ (4,853,640) $ (3,878,049) $ (18,731,120)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock based compensation 855,256 358,734 4,701,390
Stock issued for services 108,500 135,000 1,006,523
Stock to be issued for license agreement 825,000    825,000
Amortization of license fees 5,882 5,882 29,411
Amortization of discount of notes payable 141,489    141,489
Amortization of debt issuance costs 63,122    63,122
Depreciation and amortization expense 170,512 411,853 599,153
Loss on disposal of fixed assets    19,504 19,504
Impaiment of fixed assets    800,000 800,000
Impairment of goodwill       3,555,304
Gain on forgiveness of liabilities (80,656) (280,000) (360,656)
Gain on forgiveness of liabilities of discontinued operations    (104,024) (104,024)
Change in assets and liabilities      
Increase in accounts receivable (109,395) (67,919) (383,859)
Decrease (increase) in inventory 37,993 (7,371)   
Decrease (increase) in prepaid expenses and other assets 18,208 (28,626) (84,795)
Increase in accounts payable and accrued liabilities 1,271,200 74,749 2,054,642
Net cash used in operating activities (1,546,529) (2,560,267) (5,868,916)
Cash flows used in investing activities      
Purchase of license       (100,000)
Cash assumed in reverse merger       11,150
Purchase of equipment    (8,244) (1,414,602)
Net cash used in investing activities    (8,244) (1,503,452)
Cash flows from financing activities      
Payment of debt issuance costs (395,778) (125,534) (521,312)
Net proceeds from related party advances       951,034
Payment on note payable (150,000)      
Proceeds from the issuance of preferred stock, net       483,500
Proceeds from the issuance of convertible promissory notes and related warrants 2,412,545 2,570,199 4,982,744
Proceeds from the issuance of common stock, net    213,500 1,986,007
Net cash provided by financing activities 1,866,767 2,658,165 7,881,973
Net increase in cash and cash equivalents 320,238 89,654 509,605
Cash and cash equivalents - beginning of period 189,367 99,713   
Cash and cash equivalents - end of period 509,605 189,367 509,605
SUPPLEMENTAL CASH FLOW INFORMATION:      
Cash paid during the period for - Interest 13,083 9,150 24,920
SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS      
Equipment purchases included in accounts payable 112,000 112,000 112,000
Conversion of advances payable to notes payable 1,036,195    1,036,195
Conversion of debt to equity 866,211    866,211
Conversion of accrued interest to debt $ 305,496    $ 305,496